These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 15481247

  • 21. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate.
    Smith RD, Grzelak ME, Coffin VL.
    Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055
    [Abstract] [Full Text] [Related]

  • 22. Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice.
    Cuadrado A, Bravo J, Armijo JA.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):43-52. PubMed ID: 12650832
    [Abstract] [Full Text] [Related]

  • 23. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.
    Luszczki JJ, Andres-Mach MM, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Epilepsia; 2007 Apr 28; 48(4):806-15. PubMed ID: 17284299
    [Abstract] [Full Text] [Related]

  • 24. Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phases.
    Bertorelli R, Ferri N, Adami M, Ongini E.
    Pharmacol Biochem Behav; 1996 Mar 28; 53(3):559-65. PubMed ID: 8866955
    [Abstract] [Full Text] [Related]

  • 25. Felbamate: a new antiepileptic drug.
    Wagner ML.
    Am J Hosp Pharm; 1994 Jul 01; 51(13):1657-66. PubMed ID: 7942890
    [Abstract] [Full Text] [Related]

  • 26. Effect of felbamate on carbamazepine and its major metabolites.
    Wagner ML, Remmel RP, Graves NM, Leppik IE.
    Clin Pharmacol Ther; 1993 May 01; 53(5):536-43. PubMed ID: 8491065
    [Abstract] [Full Text] [Related]

  • 27. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ, Danysz W, Czuczwar SJ.
    Pharmacology; 2008 May 01; 81(3):259-65. PubMed ID: 18253065
    [Abstract] [Full Text] [Related]

  • 28. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR.
    J Pharmacol Exp Ther; 1993 Mar 01; 264(3):1248-52. PubMed ID: 8383742
    [Abstract] [Full Text] [Related]

  • 29. Influence of felbamate on the antinociceptive action of morphine, metamizol and indomethacin in mice.
    Pakulska W, Wejman I, Czarnecka E.
    Acta Pol Pharm; 2003 Mar 01; 60(3):201-6. PubMed ID: 14556489
    [Abstract] [Full Text] [Related]

  • 30. Felbamate reduces hormone release and locomotor hypoactivity induced by repeated stress of social defeat in mice.
    Pistovcakova J, Makatsori A, Sulcova A, Jezova D.
    Eur Neuropsychopharmacol; 2005 Mar 01; 15(2):153-8. PubMed ID: 15695059
    [Abstract] [Full Text] [Related]

  • 31. Effect of anticonvulsant felbamate on GABAA receptor system.
    Ticku MK, Kamatchi GL, Sofia RD.
    Epilepsia; 1991 Mar 01; 32(3):389-91. PubMed ID: 1646101
    [Abstract] [Full Text] [Related]

  • 32. Felbamate and meprobamate: a comparison of their anticonvulsant properties.
    Frey HH, Bartels I.
    Epilepsy Res; 1997 Jun 01; 27(3):151-64. PubMed ID: 9237049
    [Abstract] [Full Text] [Related]

  • 33. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V, Glue P, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Haring P, Radwanski E, Nomeir A, Lin CC.
    Clin Pharmacol Ther; 1995 Nov 01; 58(5):523-31. PubMed ID: 7586946
    [Abstract] [Full Text] [Related]

  • 34. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE, Wong KK, Kucharczyk N, Sofia RD.
    Drug Metab Dispos; 1991 Nov 01; 19(6):1135-8. PubMed ID: 1687021
    [Abstract] [Full Text] [Related]

  • 35. Weight loss in patients taking felbamate.
    Bergen DC, Ristanovic RK, Waicosky K, Kanner A, Hoeppner TJ.
    Clin Neuropharmacol; 1995 Feb 01; 18(1):23-7. PubMed ID: 8665531
    [Abstract] [Full Text] [Related]

  • 36. Influence of fluoroquinolones on the central action of ethanol.
    Strzelec JS, Kubik-Bogucka E, Czarnecka E.
    Pol J Pharmacol; 1999 Feb 01; 51(1):71-8. PubMed ID: 10389147
    [Abstract] [Full Text] [Related]

  • 37. Aminophylline (a theophylline-ethylenediamine complex) blocks ethanol behavioral effects in mice.
    Soares PM, Patrocínio MC, Assreuy AM, Siqueira RC, Lima NM, Arruda Mde O, de Souza Escudeiro S, de Carvalho KM, Sousa FC, Viana GS, Vasconcelos SM.
    Behav Pharmacol; 2009 Jul 01; 20(4):297-302. PubMed ID: 19617722
    [Abstract] [Full Text] [Related]

  • 38. Can energy drinks reduce the depressor effect of ethanol? An experimental study in mice.
    Ferreira SE, Hartmann Quadros IM, Trindade AA, Takahashi S, Koyama RG, Souza-Formigoni ML.
    Physiol Behav; 2004 Oct 15; 82(5):841-7. PubMed ID: 15451648
    [Abstract] [Full Text] [Related]

  • 39. [Preliminary assessment of felbamate effect on the cerebral bioelectrical activity in children with refractory epilepsy].
    Pakszys M, Rusek G, Kuszczak B, Szamotulska K, Mazur J.
    Neurol Neurochir Pol; 2000 Oct 15; 34 Suppl 1():203-14. PubMed ID: 10768160
    [Abstract] [Full Text] [Related]

  • 40. Single and multiple dose pharmacokinetics of felbamate in the elderly.
    Richens A, Banfield CR, Salfi M, Nomeir A, Lin CC, Jensen P, Affrime MB, Glue P.
    Br J Clin Pharmacol; 1997 Aug 15; 44(2):129-34. PubMed ID: 9278196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.